1 / 29
Murakami Lab, May 2025
2 / 29
Dr. Mingzeng Zhang presenting "Baseline Intratumoral CD4 T-cell Abundance and Frequency Correlates with Durable Clinical Response to Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) Treatment in Mantle Cell Lymphoma", December 2025
3 / 29
Stella Jaeckle presenting "Molecular and functional determinants of response to venetoclax and inotuzumab ozogamicin in CD22-positive B-AL", December 2025
4 / 29
Dinner at the American Society of Hematology (ASH) annual meeting, December 2025
5 / 29
Nina Xiong and Taiyang Chen presenting “Access to Diagnosis through Liquid Biopsy (ADLiB): expediting lymphoma diagnosis in a high-need setting” at the Hematologic Neoplasia & Immunologic Therapies Seminar, May 2025
6 / 29
Chase Weizer presenting his poster at 2025 AACR in Chicago, IL
7 / 29
Last week in the lab for summer students Rahaf and Sophie ☹, August 2025 (Left to right: Rahaf Qarabsa, Sophie Zhu, Alyssa Wu, Claire Walter, Emily Sumpena)
8 / 29
Emily Sumpena smiling her way through tissue culture work, August 2025
9 / 29
Medical student Srisha Athreya presents her work on the molecular biology of acute lymphoblastic leukemia during the finalist round at the student research summit at University College Dublin, September 2025.
10 / 29
Luzany Correia presenting his work at the End of Summer CURE Presentation, August 2025
11 / 29
End of Summer CURE Presentation by Ashreen Williams, August 2025
12 / 29
Nina Xiong working on ADLiB!
13 / 29
Rahaf Qarabsa getting down to business, August 2025
14 / 29
Lab outing to Island Creek Oyster Farm, June 2025
15 / 29
Oyster shucking at Island Creek Oyster Farm, June 2025
16 / 29
Alyssa Wu locking in, August 2025
17 / 29
Dr. Mark Murakami presenting “Ph+ Acute Lymphoblastic Leukemia: Dual TKI Therapy and Pathways of Resistance” at Hematologic Neoplasia & Immunologic Therapies Seminar, May 2025
18 / 29
Lunch with the Parry Lab, May 2025
19 / 29
Goodbye, Nina ☹ (we miss you!)
20 / 29
Claire Walter showing Rahaf Qarabsa how to process primary samples, August 2025
21 / 29
Murakami Lab, December 2024
22 / 29
Congratulations to Taiyang Chen on her excellent capstone presentation for the HMS Biomedical Informatics Master's Program in December 2024! (Left to right: Nina Xiong, Taiyang Chen, Mark Murakami)
23 / 29
Dr. Mark Murakami, Dr. Katherine Antel, Dr. Lydie Debaize, and Dr. Mingzeng Zhang (clockwise) grabbing lunch at 2023 AACR in Orlando, FL!
24 / 29
Murakami Lab, Summer 2023
25 / 29
Going away for Dr. Katherine Antel ☹, September 2023
26 / 29
Lunch with the Pikman Lab, June 2023
27 / 29
Summer outing in Fenway, July 2022
28 / 29
Lab lunch in Fenway, July 2022
29 / 29
End of Summer CURE Presentation by Mia Blennau, August 2022

About

The Murakami Lab at DFCI studies minimal residual disease in B-cell leukemia and lymphoma and aims to translate mechanistic discoveries into individualized therapies to improve patient outcomes by utilizing our repository of preclinical models including patient-derived xenograft (PDX) mouse models, access to conventional and experimental therapeutic agents, expertise in lymphoid genomics and bioinformatics, novel single-cell biophysical and molecular profiling platforms, and involvement in early phase clinical trials.